Market revenue in 2023 | USD 1,813.6 million |
Market revenue in 2030 | USD 1,993.7 million |
Growth rate | 1.4% (CAGR from 2023 to 2030) |
Largest segment | Quantitative |
Fastest growing segment | Digital |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Quantitative, Digital, End-point |
Key market players worldwide | Abbott Laboratories, Qiagen NV, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, GE Aerospace, BioMerieux SA, Roche Holding AG ADR, Fluidigm Corporation |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to real time pcr, digital pcr, and end point pcr market will help companies and investors design strategic landscapes.
Quantitative was the largest segment with a revenue share of 85.83% in 2023. Horizon Databook has segmented the Asia Pacific real time pcr, digital pcr, and end point pcr market based on quantitative, digital, end-point covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is considered to be one of the most lucrative markets across the globe. The high unmet clinical needs, untapped market opportunities, and increasing healthcare expenditure are some of the key factors expected to boost the market.
Technological advancements and the rising prevalence of various target diseases are expected to increase the demand for PCR. Furthermore, the demand for healthcare products and government initiatives to improve the population’s health is expected to drive market growth during the forecast period.
In Asia Pacific, the real-time PCR, digital PCR, and end-point PCR market is dynamic and competitive. Various factors contribute to this landscape, including technological advancements, regulatory frameworks, and investment trends.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific real time pcr, digital pcr, and end point pcr market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific real time pcr, digital pcr, and end point pcr market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account